Cargando…
Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
α-Synuclein (αS) has been well-documented to play a role in human synucleinopathies such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). First, the lesions found in PD/DLB brains—Lewy bodies and Lewy neurites—are rich in aggregated αS. Second, genetic evidence links missense mutatio...
Autores principales: | Kim, Tae-Eun, Newman, Andrew J, Imberdis, Thibaut, Brontesi, Lisa, Tripathi, Arati, Ramalingam, Nagendran, Fanning, Saranna, Selkoe, Dennis, Dettmer, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600006/ https://www.ncbi.nlm.nih.gov/pubmed/34254125 http://dx.doi.org/10.1093/hmg/ddab188 |
Ejemplares similares
-
Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
por: Terry-Kantor, Elizabeth, et al.
Publicado: (2020) -
Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
por: Tripathi, Arati, et al.
Publicado: (2021) -
Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
por: Imberdis, Thibaut, et al.
Publicado: (2019) -
Parkinson’s disease: proteinopathy or lipidopathy?
por: Fanning, Saranna, et al.
Publicado: (2020) -
α-Synuclein serine129 phosphorylation – the physiology of pathology
por: Ramalingam, Nagendran, et al.
Publicado: (2023)